Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Boston Scientific Corp. for $15.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Boston Scientific Corp. (NYSE:BSX)


Common-Size Income Statement
Quarterly Data

Beginner level

Boston Scientific Corp., common-size consolidated income statement (quarterly data)

Microsoft Excel LibreOffice Calc
3 months ended Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Net sales
Cost of products sold
Gross profit
Selling, general and administrative expenses
Research and development expenses
Royalty expense
Amortization expense
Intangible asset impairment charges
Contingent consideration (expense) benefit
Restructuring charges
Litigation-related (charges) credits
Pension termination charges
Operating expenses
Operating income (loss)
Interest expense
Other, net
Other income (expense)
Income (loss) before income taxes
Income tax (expense) benefit
Net income (loss)

Based on: 10-K (filing date: 2020-02-25), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-07-30), 10-Q (filing date: 2019-04-29), 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-10-29), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-05-01), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-11-02), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-03), 10-K (filing date: 2017-02-23), 10-Q (filing date: 2016-11-03), 10-Q (filing date: 2016-08-03), 10-Q (filing date: 2016-05-04), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-06).

Income statement item Description The company
Operating income (loss) The net result for the period of deducting operating expenses from operating revenues. Boston Scientific Corp.’s operating income (loss) as a percentage of net sales decreased from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Boston Scientific Corp.’s income (loss) before income taxes as a percentage of net sales decreased from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Boston Scientific Corp.’s net income (loss) as a percentage of net sales decreased from Q2 2019 to Q3 2019 but then increased from Q3 2019 to Q4 2019 exceeding Q2 2019 level.